(S (NP (NP (JJ Multiple) (NN sclerosis)) (-LRB- -LRB-) (NP (NN MS)) (-RRB- -RRB-)) (VP (VBZ affects) (NP (DT the) (JJ central) (JJ nervous) (NN system)) (PP (IN with) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NNS symptoms)))))) (. .))
(S (NP (NN MS)) (VP (VP (MD can) (, ,) (PP (IN for) (NP (NN example))) (, ,) (VP (VB cause) (NP (NP (NN pain)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN mood) (CC and) (NN fatigue))))))) (, ,) (CC and) (VP (MD may) (VP (VB impair) (NP (NP (NP (DT a) (NN person) (POS 's)) (NN movement)) (, ,) (NP (NN speech)) (CC and) (NP (JJ visual) (NNS functions)))))) (. .))
(S (NP (NP (NN Diagnosis)) (PP (IN of) (NP (NNP MS)))) (ADVP (RB typically)) (VP (VBZ involves) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (JJ complex) (JJ clinical) (NNS assessments) (CC and) (NNS tests)))) (S (VP (TO to) (VP (VB rule) (PRT (RP out)) (NP (JJ other) (NNS diseases)) (PP (IN with) (NP (JJ similar) (NNS symptoms))))))) (. .))
(S (NP (NP (JJ New) (NNS technologies)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN smartphone) (NN monitoring)) (PP (IN in) (NP (NML (JJ free) (HYPH -) (NN living)) (NNS conditions))))) (, ,)) (VP (MD could) (ADVP (RB potentially)) (VP (VB aid) (PP (IN in) (S (ADVP (RB objectively)) (VP (VBG assessing) (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NN MS)))) (PP (IN by) (S (VP (VBG quantifying) (NP (NN symptom) (NN presence) (CC and) (NN intensity)) (ADVP (RB over) (RB long)) (S (NP (NP (NNS periods)) (PP (IN of) (NP (NN time))))))))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT a) (NML (JJ deep) (HYPH -) (NN learning)) (NN approach)) (PP (IN to) (S (VP (VBG diagnosing) (NP (NN MS)) (PP (IN from) (NP (NP (ADJP (NP (NN smartphone)) (HYPH -) (VBN derived)) (JJ digital) (NNS biomarkers)) (SBAR (WHNP (WDT that)) (S (VP (VBZ uses) (NP (NP (DT a) (JJ novel) (NN combination)) (PP (IN of) (NP (NP (DT a) (JJ multilayer) (NN perceptron)) (PP (IN with) (NP (JJ neural) (JJ soft) (NN attention)))))) (S (VP (TO to) (VP (VB improve) (NP (NP (NN learning)) (PP (IN of) (NP (NP (NNS patterns)) (PP (IN in) (NP (NML (JJ long) (HYPH -) (NN term)) (NN smartphone) (NN monitoring) (NNS data)))))))))))))))))) (. .))
(S (S (VP (VBG Using) (NP (NNS data)) (PP (IN from) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (CD 774) (NNS participants))))))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (PRP$ our) (NML (JJ deep) (HYPH -) (NN learning)) (NNS models)) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB distinguish) (PP (IN between) (NP (NNS people))) (PP (IN with) (CC and) (IN without) (NP (NN MS))) (PP (IN with) (NP (DT an) (NN area))) (PP (IN under) (NP (NP (DT the) (NN receiver)) (VP (VBG operating) (NP (NP (JJ characteristic) (NN curve)) (PP (IN of) (NP (CD 0.88))))))) (PRN (-LRB- -LRB-) (NP (NML (CD 95) (NN %)) (NN CI)) (: :) (NP (CD 0.70) (, ,) (CD 0.88)) (-RRB- -RRB-)))))))))) (. .))
(S (NP (PRP$ Our) (JJ experimental) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ digital) (NNS biomarkers)) (VP (VBN derived) (PP (IN from) (NP (NN smartphone) (NNS data))))) (VP (MD could) (PP (IN in) (NP (DT the) (NN future))) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (JJ additional) (JJ diagnostic) (NNS criteria)) (PP (IN for) (NP (NNP MS.))))))))))))
